Bibliografía
1.
LeRoy EC, Medsger TA Jr.
Raynaud´s phenomenom: a proposal for calssification. Cli
Exp Rheumatol 1992; 10:485-8
2.
Luggen M, Belhorn L, Evans T, et al.
The evolution of Raynaud´s phenomenom: a longterm
prospective study. J Rheumatol 1995; 22:2226-32.
3.
Spencer-Green G. Outcomes in primary Raynaud phenomenom:
a meta-analysis of the frequency, rates, and predictors
of transition to secondary diseases. Arch Intern Med
1998; 158:595-600.
4.
García-Carrasco M, Sisó A, Ramos-Casals M, et al. El
tratamiento del fenómeno de Raynaud. Rev Esp Reumatol
2000; 27:322-327.
5.
Wigley FM. Raynaud´s phenomenom. N Engl J Med
2002;347:1001-8.
6.
Thompson SE, Shea B, Welch V, et al.
Calcium-channel blockers for Raynaud´s phenomenom in
systemic sclerosis. Arthritis Rheum 2001;44:1841-7
7.
Bowling JC, Doed PM. Raynaud´s disease. Lancet
2003;361:2078-80.
8.
Roman Ivorra J. Treatment of Raynaud´s phenomenom. Med
Clin (Barc) 2004; 122:499-500.
